Galleri® Multi-Cancer Early Detection Test
Take control of your health with proactive cancer screening.
The Galleri® test is a simple blood draw that screens for a signal shared by 50 + types of cancer — many that currently have no recommended screening tests. By detecting subtle DNA changes before symptoms appear, this breakthrough test helps you and your doctor act sooner when treatment can be most effective.
How It Works
Order the Galleri test
We will prescribe Galleri and arrange delivery of your test kit.
Complete a simple blood draw
No fasting needed — just stay hydrated. Visit a partner lab or have a mobile phlebotomist come to you.
Sample analysis at the GRAIL lab
Your blood sample is processed in GRAIL’s CLIA-certified, CAP-accredited laboratory using advanced methylation DNA analysis.
Results in about 2 weeks
You’ll receive secure results to review with your healthcare provider and determine any next steps.
How Does the Galleri Test Work?
Using the latest scientific discoveries and DNA sequencing technology, the Galleri multi-cancer early detection test screens hundreds of thousands of DNA sites in the most informative DNA regions
The Galleri test results provide direction to your healthcare provider and help guide the next steps for diagnosis. Watch the video below to learn more about how the test works.
Why Early Detection Matters
Cancer often grows silently. By the time symptoms appear, the disease may already be advanced. Early detection dramatically increases the chance of successful treatment.
Traditional screenings check for only five cancers — breast, cervical, colon, lung (at-risk patients), and prostate. Yet nearly 70 percent of cancers have no standard screening at all. Galleri® helps fill that gap by identifying DNA fragments shed by cancer cells into the bloodstream.
Who Should Get the Galleri Test
Galleri is recommended for adults with an elevated risk for cancer, including those aged 50 and older or anyone with a family history of cancer.
The test may be right for you if you:
The test is not recommended for those under 21, pregnant, or currently receiving active cancer treatment.
Cancer Signal Detection Sensitivity
See the Science Behind Early Detection
The Galleri® test measures the presence of cancer-related DNA fragments circulating in your blood. The chart below shows the proportion of people with confirmed cancers who received a “Cancer Signal Detected” result during clinical validation.
This demonstrates how the test performs across more than 50 types of cancer, with particularly strong detection in cancers that are often found late — such as liver, bile duct, pancreas, and ovarian cancers.
Results are based on clinical data from GRAIL’s PATHFINDER and Circulating Cell-Free Genome Atlas (CCGA) studies.
Note: Some cancers are more easily detected through a blood test than others. Detection rates vary depending on tumor type, size, and stage. The Galleri test should always be used alongside your provider’s recommended screenings.
Understanding Your Results
Cancer Signal Detected
No Cancer Signal Detected
Nearly 99 percent of people receive this result — which means no DNA associated with cancer was found. Continue regular screenings as recommended.
Cancer Signal Detected
A signal was identified and linked to a likely tissue origin (Cancer Signal Origin). Your provider will review the results and recommend follow-up diagnostic testing to confirm whether cancer is present.
Understanding a Cancer Signal Detected Result
In the video below, we will review what a Cancer Signal Detected result means. Watch it to learn more.
Book Your Galleri Test Today
Be proactive about your health. Contact our office today to schedule your Galleri test and take the first step toward greater peace of mind.
Call or text us at 424-279-6337
or
Book Your Galleri Test Today
The Galleri test is intended for use in adults with an elevated risk for cancer, such as those age 50 or older. It should be used in addition to routine screening tests recommended by your healthcare provider.
Galleri does not detect all cancers and should not replace diagnostic procedures. False positive and false negative results may occur. A Cancer Signal Detected result requires follow-up diagnostic testing to confirm whether cancer is present. Rx only.
Lab Information: The GRAIL clinical laboratory is CLIA-certified and CAP-accredited to perform high-complexity testing. The Galleri test has not been cleared or approved by the U.S. Food and Drug Administration.